Table 1 Correlation of PLZF expression with the clinicopathological features of GBC
From: PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2
| Â | PLZF (high) | PLZF (low) | P-value | ||
|---|---|---|---|---|---|
|  | N = 31 | % | N = 49 | % |  |
Sexual | Â | Â | Â | Â | 0.249 |
 Male | 7 | 8.8 | 17 | 21.2 |  |
 Female | 24 | 30.0 | 32 | 40.0 |  |
Age (years) | Â | Â | Â | Â | 0.702 |
 <65 | 14 | 17.5 | 20 | 25.0 |  |
 ≥65 | 17 | 21.3 | 29 | 36.2 |  |
Tumor size (cm) | Â | Â | Â | Â | 0.444 |
 <4 | 16 | 20.0 | 21 | 26.2 |  |
 ≥4 | 15 | 18.8 | 28 | 35.0 |  |
Differential grade | Â | Â | Â | Â | 0.851 |
 I–II | 19 | 23.8 | 29 | 36.2 |  |
 III–IV | 12 | 15.0 | 20 | 25.0 |  |
TNM stage | Â | Â | Â | Â | 0.012* |
 I–II | 19 | 23.8 | 16 | 20.0 |  |
 III–IV | 12 | 15.0 | 33 | 41.2 |  |
Lymph node metastasis | Â | Â | Â | Â | 0.102 |
 No | 26 | 32.5 | 33 | 41.2 |  |
 Yes | 5 | 6.3 | 16 | 20.0 |  |
Distant metastasis | Â | Â | Â | Â | 0.008* |
 No | 25 | 31.3 | 25 | 31.2 |  |
 Yes | 6 | 7.5 | 24 | 30.0 |  |